Handelsbanken Fonder’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
Other funds holding HAE
RRAM
FWIA
BTW
Handelsbanken Fonder's HAE Position: Q2 2026 in Review
Handelsbanken Fonder increased its Haemonetics (HAE) stake by 15% in Q2 2026, buying an estimated $141K and bringing the position to 16,895 shares worth $1.27M. The position accounts for ﹤0.01% of the portfolio, ranked #1027.
Handelsbanken Fonder first reported a position in HAE in Q2 2020 and has held it in 25 quarters since. The position peaked at $1.37M in Q3 2024. 202 funds tracked by Wall St. Rank hold HAE as of Q2 2026.
- Handelsbanken Fonder held 16,895 shares of Haemonetics worth $1.27M as of Q2 2026.
- Handelsbanken Fonder bought 2,200 Haemonetics shares in Q2 2026, an estimated $141K.
- Haemonetics made up ﹤0.01% of Handelsbanken Fonder's portfolio in Q2 2026, its #1027 holding.
- Handelsbanken Fonder first reported a position in Haemonetics in Q2 2020 and has held it in 25 quarters since.
- Handelsbanken Fonder's Haemonetics position peaked at $1.37M in Q3 2024.
- 202 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.
Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.